au.\*:("OPTION Investigators")
Results 1 to 1 of 1
Selection :
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. CommentaryBONGARTZ, Tim; SMOLEN, Josef S; BEAULIEU, Andre et al.Lancet (British edition). 2008, Vol 371, Num 9617, issn 0140-6736, 961-963, 987-997 [14 p.]Article
